Loading company
Loading
Open Financials GT Biopharma, Inc. (GTBP) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Cash from operating activities | -$12.9 million | -$12.9 million | 10-K 2026-03-02 · proof |
- What was GT Biopharma, Inc. (GTBP)'s cash from operating activities in fiscal 2025?
- GT Biopharma, Inc. (GTBP) reported cash from operating activities of -$12.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$12.9 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:GTBP&period_type=annual&limit=5"Information only, not investment advice.